Tips and Tricks

Solution-specific tips you can use

What’s new in the Rehabilitation Program?

Our dedicated Rehabilitation Program team has prepared some helpful tips and updates for you and your team members. Please socialize within your offices.

Effective June 12, 2022, an AIM Specialty Health (AIM) clinical guideline update was applied for the Rehabilitation Program. If you or your facility would like to view the updated guidelines, please visit our Rehabilitation Program microsite resource page.

Effective June 12, 2022, enhancements to the Rehabilitation Program “order requests checklists” resource for providers were implemented. This resource now includes examples of appropriate and inappropriate documentation of therapy services in coordination with the AIM clinical guideline update. To view this helpful resource, please visit our Rehabilitation Program microsite resource page.

The last 2022 Rehabilitation Program Q&A provider training session is scheduled for November 8, 2022. Providers can check the microsite for 2023 quarterly session dates and sign-up for a future training session on our Rehabilitation Program microsite

Requesting drugs with Oncological and Non-Oncological Uses

Our medical reviewer teams frequently receive questions on drugs used for both oncological and non-oncological indications. To help ensure you and your peers know who to contact for authorization, we’ve assembled a guide for commonly requested drugs and possible diagnoses.

As a reminder, the AIM Medical Oncology Program will only accept requests for drugs with a primary cancer diagnosis. For patients with a non-cancer primary diagnosis, check with the member’s health plan to verify if another entity needs to authorize the requested drug.

Below are examples of how a primary and/or secondary diagnosis may be presented for drugs used to treat side effects related to cancer treatment.

    • Primary= the cancer has caused/contributed to a secondary diagnosis being treated by the requested agent
    • Secondary= the diagnosis being treated by the requested agent

If the primary diagnosis is cancer and the drug is being used to treat side effects related to cancer treatment, then the request can be submitted to AIM. However, AIM does not support or include reviews of secondary diagnoses. Please check with your ordering provider about the primary diagnosis prior to submitting a request with a specific entity.

DrugPrimary DiagnosisSecondary DiagnosisReview performed by AIM
FilgrastimNeutropenia, unspecifiedNone; no cancer caused or contributed to neutropeniaNo
FilgrastimBreast cancerNeutropenia related to infection related to cancer treatmentYes
EpoetinIron deficiency anemiaNone; no cancer has caused or contributed to iron deficiency anemiaNo
EpoetinColon cancerAnemia related to cancer treatmentYes
ProliaPrimary OsteopeniaNone; no cancer that has caused or contributed to osteopeniaNo
ProliaBreast cancerOsteopenia related to hormone replacement used for cancer treatmentYes

Utilize the Radiation Oncology Order Request Worksheets

The Radiation Oncology program has comprehensive order request checklists to help providers identify and collect the information in advance to have it available when entering requests using the AIM ProviderPortal. We recommend printing a copy or saving it to your computer to keep it handy when you’re preparing to submit an order.

The order request checklists and other helpful program resources can be found at https://aimproviders.com/radoncology/resources/.

What’s new in the Musculoskeletal Program?

Our dedicated Musculoskeletal Program team has prepared some helpful tips and updates for you and your team members.

    • Tip #1: The Musculoskeletal Program microsite is a valuable source of information that provides details on the AIM Musculoskeletal program. The Resources section on the microsite includes downloadable “order request checklists”, which will tell you what information you’ll need enter your request.
    • Tip #2: For cases that require documents to be uploaded, a list of documents will be made available that are required to complete the review of the case. For best results, upload documentation prior to submitting the order request.

Effective September 11, 2022, an AIM Specialty Health (AIM) clinical guideline update was applied for the Musculoskeletal Program. If you would like to view the updated guidelines, please visit our Musculoskeletal Program clinical guidelines page.

The last 2022 Musculoskeletal Program Q&A provider training session is scheduled for November 10, 2022. Providers can check the microsite for 2023 quarterly session dates and sign-up for a future training session on our Musculoskeletal Program microsite.

Tips for maintaining a smooth AIM ProviderPortal experience:

  • Reboot daily – most programs have releases where new or existing functionality is updated; rebooting ensures that those most recent updates are reflected in your computer.
  • Clear cookies and cache – periodically clearing your cookies and cache can keep your computer “clean” and promote efficiency. If you don’t know how, contact your IT department.
  • Use the right browser – Use Google Chrome for optimal use of the AIM ProviderPortal. Please note that Internet Explorer (IE) has been retired.